Search - tctmd.com

Displaying 361 - 380 of 946

Sort: Relevancy | Date

News Daily News

Best Degree of Oversizing Varies by TAVR Device

Caitlin E. Cox

April 17, 2015

News Daily News

Transcatheter Tricuspid Valve Repair Appears Feasible in First-in-Human Case

April 03, 2015

News Daily News

As TAVR Evolves, Local Anesthesia Could Be an Option for Lower-Risk Patients

Yael L. Maxwell

April 03, 2015

News Daily News

Reparación Transcatéter de la Válvula Tricúspide Viable en el 1er Caso en Humanos

April 03, 2015

News Industry News

Medtronic CoreValve® System Receives FDA Approval for Transcatheter Valve-In-Valve Procedures

March 31, 2015

News Industry News

Medtronic Announces Japanese Regulatory Approval of CoreValve® System

March 30, 2015

News Daily News

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

March 25, 2015

News Conference News ACC 2015

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

Todd Neale

March 20, 2015

News Conference News ACC 2015

DEFLECT III: TAVR Neuroprotection Device Safely Reduces Lesion Volume

Yael L. Maxwell

March 16, 2015

Presentation ACC 2015

Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial

Presenter: Michael J. Mack

March 15, 2015

Presentation ACC 2015

A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed at Increased Risk for Surgery 2-Year Outcomes

Presenter: Michael J. Reardon

March 15, 2015

News Conference News ACC 2015

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

Yael L. Maxwell

March 15, 2015

News Industry News

SAPIEN 3 Valve Demonstrates Low Mortality, Excellent 30-Day Outcomes In High- And Intermediate-Risk Patients

March 15, 2015

News Industry News

Medtronic CoreValve® System Sustains Superior Survival Benefit Over Open Heart Surgery at Two Years

March 15, 2015

News Conference News ACC 2015

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

Todd Neale

March 15, 2015

News Industry News

Five-Year Outcomes For High-Risk Sapien Patients Demonstrate Equivalence To Surgery, Durable Valve Performance

March 15, 2015

Presentation

Clinical Outcomes at 1 Year Following Transcatheter Aortic Valve Replacement

Presenter: David Holmes Jr.

March 10, 2015

News Daily News

TVT Registry Provides Picture of TAVR Risk Factors, 1-Year Outcomes

L.A. McKeown

March 10, 2015

News Daily News

瓣膜成形术能够改善接受药物治疗的主动脉瓣狭窄患者的短期前景(1)

February 19, 2015

News Daily News

瓣膜成形术能够改善接受药物治疗的主动脉瓣狭窄患者的短期前景

Salynn Boyles

February 19, 2015

Advertisement

Best Degree of Oversizing Varies by TAVR Device

Transcatheter Tricuspid Valve Repair Appears Feasible in First-in-Human Case

As TAVR Evolves, Local Anesthesia Could Be an Option for Lower-Risk Patients

Reparación Transcatéter de la Válvula Tricúspide Viable en el 1er Caso en Humanos

Medtronic CoreValve® System Receives FDA Approval for Transcatheter Valve-In-Valve Procedures

Medtronic Announces Japanese Regulatory Approval of CoreValve® System

PARTNER at 5 Years: TAVR Shows Durable Benefit in Inoperable Patients

ACC-i2 2015: Strategies to Enhance PCI Results, TAVR Highlighted

DEFLECT III: TAVR Neuroprotection Device Safely Reduces Lesion Volume

Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial

A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed at Increased Risk for Surgery 2-Year Outcomes

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

SAPIEN 3 Valve Demonstrates Low Mortality, Excellent 30-Day Outcomes In High- And Intermediate-Risk Patients

Medtronic CoreValve® System Sustains Superior Survival Benefit Over Open Heart Surgery at Two Years

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

Five-Year Outcomes For High-Risk Sapien Patients Demonstrate Equivalence To Surgery, Durable Valve Performance

Clinical Outcomes at 1 Year Following Transcatheter Aortic Valve Replacement

TVT Registry Provides Picture of TAVR Risk Factors, 1-Year Outcomes

瓣膜成形术能够改善接受药物治疗的主动脉瓣狭窄患者的短期前景(1)

瓣膜成形术能够改善接受药物治疗的主动脉瓣狭窄患者的短期前景

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content